2020
DOI: 10.1212/wnl.0000000000008959
|View full text |Cite
|
Sign up to set email alerts
|

Quantitative oculomotor and nonmotor assessments in late-onset GM2 gangliosidosis

Abstract: ObjectiveA cross-sectional study was performed to evaluate whether quantitative oculomotor measures correlate with disease severity in late-onset GM2 gangliosidosis (LOGG) and assess cognition and sleep as potential early nonmotor features.MethodsTen patients with LOGG underwent quantitative oculomotor recordings, including measurements of the angular vestibulo-ocular reflex (VOR), with results compared to age- and sex-matched controls. Disease severity was assessed by ataxia rating scales. Cognitive/neuropsyc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
30
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 17 publications
(33 citation statements)
references
References 42 publications
(57 reference statements)
3
30
0
Order By: Relevance
“…Similar to a recent study involving nineteen Belgian individuals with Friedreich ataxia, all SCA3 mutation carriers failed at least one CCAS-S item [ 38 ]. The high sensitivity of the CCAS-S to detect cognitive impairment in cerebellar diseases was further supported by an evaluation of ten individuals with late-onset GM2 gangliosidosis [ 39 ]. Whereas subjective cognitive complaints had been reported by only one patient or caregiver, five out of ten met criteria for definite CCAS, two for probable CCAS, and two for possible CCAS, sometimes even in the absence of brain MRI abnormalities.…”
Section: Discussionmentioning
confidence: 99%
“…Similar to a recent study involving nineteen Belgian individuals with Friedreich ataxia, all SCA3 mutation carriers failed at least one CCAS-S item [ 38 ]. The high sensitivity of the CCAS-S to detect cognitive impairment in cerebellar diseases was further supported by an evaluation of ten individuals with late-onset GM2 gangliosidosis [ 39 ]. Whereas subjective cognitive complaints had been reported by only one patient or caregiver, five out of ten met criteria for definite CCAS, two for probable CCAS, and two for possible CCAS, sometimes even in the absence of brain MRI abnormalities.…”
Section: Discussionmentioning
confidence: 99%
“…In fact, it is not uncommon to uncover cerebellar symptoms and imaging evidence of cerebellar atrophy at the time of LOTS’s diagnosis regardless of the presenting symptoms. The combination of cerebellar signs and symptoms including mild dysmetria, eye movement abnormalities [ 30 32 ], cerebellar dysarthria [ 32 34 ], subtle long tract findings and lower extremity weakness may be easily mistaken for one of the spinocerebellar ataxias [ 35 ] ( Table 1 ), In contrast to infantile GM2 gangliosidoses, the presence of a cherry red macula on fundoscopic exam of an adult with ataxia and myoclonus is highly suggestive of an alternate diagnosis of sialidosis type-I or galactosialidosis not LOTS or LOSD. Amongst symptoms related to cerebellar dysfunction, none seem as disabling as the progressive dysarthria of patients with LOTS including characteristic cerebellar features with unique superimposed fast pace, pressured, stuttering and/or explosive quality, that progressively impacts communicative abilities [ 32 34 ].…”
Section: Gm2 Is a Disease Continuummentioning
confidence: 99%
“…There is debate as to the degree to which cerebellar atrophy and cerebellar dysfunction, including dysarthria, might be more prevalent and severe in LOTS as compared to LOSD. These differences could result in cases with distinct cerebellar syndromes in LOTS and distinct neuromuscular phenotypes in LOSD [ 29 , 30 , 36 ].…”
Section: Gm2 Is a Disease Continuummentioning
confidence: 99%
“…Its major representative ethnic group of patients is from Japan ( from Kansai and Okinawa region), South Korea, Taiwan, and Brazilian patients from Japanese ancestry. Allelic conditions include autosomal recessive hereditary spastic paraplegia type 57 (SPG57) and extraskeletal myxoid chondrosarcoma 43,44,45,46 .…”
Section: Okinawa Type Spinal Muscular Atrophymentioning
confidence: 99%